CAS: 1664-40-0; N-Phenylethylenediamine

上下游产品

CAS号2576-47-8 2-溴乙胺氢溴酸盐 | CAS号591-50-4 碘苯 | CAS号107-15-3 乙二胺 | CAS号4916-20-5 3-anilinopropan... | CAS号497-25-6 2-恶唑烷酮 | CAS号142-04-1 苯胺盐酸盐 | CAS号3009-97-0 苯胺基乙腈 | CAS号151-56-4 氮丙啶 | CAS号870-24-6 2-氯乙胺盐酸盐 | CAS号1069085-53-5 2-(全氟丙基)-1-苯基-4... | CAS号1069085-41-1 1-苯基-2-(三氟甲基)-4... | CAS号1069085-50-2 2-(二氟甲基)-1-苯基-4... | CAS号90917-86-5 1-苯基哌嗪-2-酮 | CAS号124-40-3 二甲胺 | CAS号13670-24-1 2-ethyl-1-pheny... | CAS号13670-23-0 N-(2-anilinoeth... | CAS号1848-69-7 1-苯基咪唑-2-酮 | CAS号111154-10-0 N-(2-anilinoeth...

N,N-Dibenzyl-N'-Phenyl-Ethylenediamine置于钯,溶剂黄146体系中,化学反应生成N-苯基乙二胺
参考文献:De550762
标题:De550762

专利信息

专利号:WO-0140193-A1
优先权日:1999-12-03
标题:Method for the synthesis of pyrazolines
发明人：BOLDI ARMEN M
权利人:CHEMRX ADVANCED TECHNOLOGIES I; BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula (I). Also claimed are novel intermediates and their methods of synthesis.

专利号:US-2002103381-A1
优先权日:2000-11-30
标 题 :Method for the synthesis of pyrazolines
发明人：BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula I: n n n Also claimed are novel intermediates and their methods of synthesis.

专利号:US-2013102730-A1
优先权日:2010-04-02
标 题:Polyamine-containing polymers and methods of synthesis and use
发明人：JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN
权利人:JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN; ALBERTA INNOVATES TECHNOLOGY FUTURES
摘要:The present invention relates to polyamine-containing polymers and methods of their synthesis and use. The polymer may be hydroxyethylcellulose, dextran, poly(vinyl alcohol) or poly(methyl acrylate).

专利号:US-2024279231-A1
优先权日:2021-05-20
标题:Map4k4 inhibitors and methods of synthesis and use thereof
发明人：AWASTHI VIBHUDUTTA; EEDA VENKATESWARARAO
权利人:UNIV OKLAHOMA
摘要:The compound DMX-5804, IUPAC name 5-(4-(2-methoxyethoxy)phenyl)-7-phenyl-3,4a,7,7a-tetrahydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, is a potent and selective inhibitor of mitogen-activated protein kinase kinase kinase kinase-4 (MAP4K4). The present disclosure describes a scalable and practical synthesis process for making DMX-5804. The process (1) doesn't rely on transition metals, (2) has reduced duration of reactions, (3) is streamlined with significantly improved yields using low cost raw materials, (4) includes no microwave-assisted reactions, (5) does not require column purification, and (6) generally results in crystalized products having over a 95% purity in each step. The present disclosure also describes DMX-5804 analogs and derivatives for use in inhibiting MAP4K4, and scalable and practical processes for making such DMX-5804 analogs.

专利号:US-7968075-B2
优先权日:2009-03-04
标 题:Multi-element metal chalcogenide and method for preparing the same
发明人：CHUNG JUN-WEN
权利人:HELIOHAWK OPTOELECTRONICS CORP
摘要:A multi-element metal chalcogenide and a method for preparing the same are provided. The multi-element metal chalcogenide includes multiple metal elements. A multi-element metal chalcogenide powder is prepared, and all of the multiple metal elements of the multi-element metal chalcogenide are derived from at least one of simple substance powders of the metal elements and one or more alloy powders mixed in accordance with a mole ratio. A solution phase synthesis of the powder of the multi-element metal chalcogenide is then conducted under normal pressure to prepare the multi-element metal chalcogenide. The multi-element metal chalcogenide can be coated to obtain a film or used to make a target and then bombard the target for sputtering a film. In such a way, a selenization process which is conventional in fabricating the semiconductor solar cell is eliminated, thus improving production yield and efficiency.

专利号:US-8003785-B2
优先权日:2008-06-18
标 题 :Halo-substituted pyrimidodiazepines
发明人：CAI JIANPING; CHEN SHAOQING; CHU XIN-JIE; LUK KIN-CHUN; MISCHKE STEVEN GREGORY; SUN HONGMAO; WOVKULICH PETER MICHAEL
权利人:TAKEDA PHARMACEUTICAL
摘要:The present invention provides PLK1 inhibitor compounds of formula I: n nuseful in the treatment or control of cell proliferative disorders, particularly oncological disorders. These compounds and formulations containing such compounds may be useful in the treatment or control of solid tumors, such as, for example, breast, colon, lung and prostate tumors and other oncological diseases such as non-Hodgkin's lymphomas. Also provided are intermediate compounds useful in the synthesis of compounds of formula I.